In Vitro-In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs

被引:31
|
作者
Kunze, Annett [1 ,2 ]
Huwyler, Joerg [2 ]
Poller, Birk [1 ]
Gutmann, Heike [1 ]
Camenisch, Gian [1 ]
机构
[1] Novartis Inst BioMed Res, Drug Drug Interact Sect, Div Drug Metab & Pharmacokinet, CH-4056 Basel, Switzerland
[2] Univ Basel, Div Pharmaceut Technol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
关键词
in vitro-in vivo correlations (IVIVC); renal clearance; renal reabsorption; permeability; drug transport; in vitro models; membrane transport; pharmacokinetics; LLC-PK1 cell line; clearance prediction; TRANSCELLULAR TRANSPORT; MEMBRANE TRANSPORTERS; LLC-PK1; KIDNEY; PARAMETERS; METABOLISM; MECHANISMS; MONOLAYERS; EXPRESSION; MODEL;
D O I
10.1002/jps.23851
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Renal clearance is a key determinant of the elimination of drugs. To date, only few in vitro-in vivo extrapolation (IVIVE) approaches have been described to predict the renal organ clearance as the net result of glomerular filtration, tubular secretion, and tubular reabsorption. In this study, we measured in LLC-PK1 cells the transport of 20 compounds that cover all four classes of the Biopharmaceutical Drug Disposition System. These data were incorporated into a novel kidney model to predict all renal clearance processes in human. We showed that filtration and secretion were main contributors to the renal organ clearance for all compounds, whereas reabsorption was predominant for compounds assigned to classes 1 and 2. Our results suggest that anionic drugs were not significantly secreted in LLC-PK1 cells, resulting in under-predicted clearances. When all study compounds were included a high overall correlation between the reported and predicted renal organ clearances was obtained (R-2 = 0.83). The prediction accuracy in terms of percentage within twofold and threefold error was 70% and 95%, respectively. In conclusion, our novel IVIVE method allowed to predict the human renal organ clearance and the contribution of each underlying process. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:994 / 1001
页数:8
相关论文
共 50 条
  • [21] In vitro-in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization
    Morita, Keiichi
    Kato, Motohiro
    Kudo, Toshiyuki
    Ito, Kiyomi
    XENOBIOTICA, 2020, 50 (09) : 1064 - 1075
  • [22] Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro-In Vivo Extrapolation of Clearance of Prodrugs
    Nishimuta, Haruka
    Houston, J. Brian
    Galetin, Aleksandra
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (09) : 1522 - 1531
  • [23] Application of Empirical Scalars To Enable Early Prediction of Human Hepatic Clearance Using In Vitro-In Vivo Extrapolation in Drug Discovery: An Evaluation of 173 Drugs
    Jones, Robert S.
    Leung, Christian
    Chang, Jae H.
    Brown, Suzanne
    Liu, Ning
    Yan, Zhengyin
    Kenny, Jane R.
    Broccatelli, Fabio
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (08) : 1053 - 1063
  • [24] Prediction of metabolic drug clearance in humans:: In vitro-in vivo extrapolation vs allometric scaling
    Shiran, M. R.
    Proctor, N. J.
    Howgate, E. M.
    Rowland-Yeo, K.
    Tucker, G. T.
    Rostami-Hodjegan, A.
    XENOBIOTICA, 2006, 36 (07) : 567 - 580
  • [25] In vitro kinetics and quantitative in vitro-in vivo extrapolation of nephrotoxicants
    Kramer, N.
    Taverne, F.
    Mally, A.
    Jarzina, S.
    Birk, B.
    DiFiore, S.
    Ellinger, B.
    Gehring, R.
    TOXICOLOGY LETTERS, 2018, 295 : S137 - S137
  • [26] In vitro-in vivo extrapolation of hepatic clearance involving active uptake:: Theoretical and experimental aspects
    Webborn, P. J. H.
    Parker, A. J.
    Denton, R. L.
    Riley, R. J.
    XENOBIOTICA, 2007, 37 (10-11) : 1090 - 1109
  • [27] IN VITRO TO IN VIVO EXTRAPOLATION OF CLEARANCE TO PREDICT STEREOSELECTIVE DISPOSITION OF BUPROPION.
    Bamfo, N.
    Quinney, S.
    Elmokadem, A.
    Silva, L.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S7 - S8
  • [28] Complexities of glucuronidation affecting in vitro-in vivo extrapolation
    Lin, JH
    Wong, BK
    CURRENT DRUG METABOLISM, 2002, 3 (06) : 623 - 646
  • [29] Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation
    Scotcher, Daniel
    Jones, Christopher
    Posada, Maria
    Galetin, Aleksandra
    Rostami-Hodjegan, Amin
    AAPS JOURNAL, 2016, 18 (05): : 1082 - 1094
  • [30] Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation
    Daniel Scotcher
    Christopher Jones
    Maria Posada
    Aleksandra Galetin
    Amin Rostami-Hodjegan
    The AAPS Journal, 2016, 18 : 1082 - 1094